Stress and Resilience Town Halls Are Being Offered
The Yale Department of Psychiatry continues to offer virtual “Stress and Resilience Town Halls” over Zoom that are open to all faculty, residents, and staff at Yale School of Medicine and Yale New Haven Health. Virtual meetings will run for up to an hour. Individuals can attend as frequently as they like.
Yale Scientists Awarded $8.4M Grant to Develop Treatments for Women With Problem Drinking
Yale Department of Psychiatry scientists have been awarded a five-year, $8.4 million federal grant to establish a new research center at Yale that will develop treatments to help women with problem drinking.
Moderate-to-High Posttraumatic Stress Common after Exposure to Trauma, Violence, Study Finds
Over 30 percent of injury survivors who are treated in hospital emergency departments will have moderate-to-severe symptoms of posttraumatic stress disorder (PTSD) at some point in the first year following the initial incident, new research led by the Yale School of Public Health finds.
Yale Genomics Study: Helping Researchers Better Understand the Opioid Epidemic
A human genomics study led by two Yale Department of Psychiatry researchers identified specific genetic regions that link opioid exposure and dependence to neuropsychiatric traits like risk-taking behaviors, alcohol abuse, and depression.
Sullivan, Meyer Awarded Grant to Study Intimate Partner Violence Among Women Living with HIV
Tami Sullivan, PhD, Associate Professor of Psychiatry and Director of Family Violence Research and Programs, and Jaimie Meyer, MD, MS, Assistant Professor of Medicine and Assistant Clinical Professor of Nursing, have been awarded a new grant to study intimate partner violence among women living with HIV.
Major Gift Will Endow a Program Devoted to a Fuller Understanding of How the Human Brain Works
The Thomas Kingsley Lawrence ’19 Program in Brain Research will take a multifaceted approach to understanding the higher-order functionality of the human brain and related areas. It is hoped that with the knowledge gained, novel prevention strategies, diagnostics, and therapeutics to reduce the incidence, prevalence, and recurrence of psychiatric disorders will be possible.
Spreading HAPPINESS in Nigeria: Yale, Partners Expand Mental Health Program
On Jan. 17, during a four-day trip to Nigeria that is part of the Yale Africa Initiative, Yale President Peter Salovey met with officials to finalize plans for expanding the HAPPINESS Project, a program of the Yale Department of Psychiatry.
Yale Study: Ketamine Disinhibits Dendrites and Enhances Calcium Signals in Prefrontal Dendritic Spines
In a study published in Nature Communications, Alex Kwan, PhD, Associate Professor of Psychiatry, and his research team found that within an hour after a mouse received ketamine, there is a substantial increase in the amount of calcium that goes into the dendritic spines for neurons in the prefrontal cortex.
Yale Psychiatry to Launch Public Psychiatry Track
The Yale Department of Psychiatry is creating a new track for residents who are interested in the field of Public/Community Psychiatry, broadly defined as the treatment of individuals with serious mental illness and substance use disorders who receive services supported by public funds.
Yale Review: How Brain Alterations Contribute to Suicidal Thoughts and Behaviors
How brain alterations contribute to suicidal thoughts and behaviors is the subject of a new published review of brain scanning studies by Yale and international researchers. Hilary Blumberg, MD, John and Hope Furth Professor of Psychiatric Neuroscience, and Professor of Psychiatry, in the Child Study Center and of Radiology and Biomedical Imaging at Yale, is the paper's lead and corresponding author.
Buono Will Lobby Congress to Increase Funding for Neurofibromatosis
Frank D. Buono, PhD, Associate Research Scientist in Psychiatry, will lobby members of Congress on behalf of several advocacy groups in Washington, D.C. in February 2020 to increase funding for the rare genetic disease called Neurofibromatosis (NF).
Study Suggests Role for Targeting Psychological Variables in the Treatment of Opioid Use Disorder and Chronic Pain
There is a paucity of evidence-based treatments for co-occurring opioid use disorder and chronic pain. These inter-related chronic medical conditions have been central to the unfolding of the opioid crisis. A new study by researchers at Yale, Johns Hopkins, University of Bridgeport, and Western Connecticut State University published in the Journal of Clinical Psychology suggests that psychological variables are important treatment targets for co-occurring opioid use disorder and chronic pain.